Send to:

Choose Destination
See comment in PubMed Commons below
Vaccine. 2009 Dec 10;28(1):110-3. doi: 10.1016/j.vaccine.2009.09.108. Epub 2009 Oct 9.

Antibody response to influenza immunization in coronary artery disease patients: a controlled trial.

Author information

  • 1Clinical Research & Development Center, Shahid Modarres Medical Center, Shahid Beheshti University (MC), Tehran, Iran. maryam


Safety of and humoral immune response to the anti-influenza vaccine in coronary artery disease (CAD) patients were evaluated. The trivalent vaccine was administered to 137 eligible CAD patients and 67 age- and sex-matched healthy individuals. Antibody (Ab) titers were measured before and 1 month after vaccination. CAD and HC groups were not significantly different in serologic response and magnitude of change in antibody titers against each of the vaccine antigens. In multivariate analyses, regular exercise and using multivitamin supplements were independently associated with better antibody response among CAD patients. There were no major cardiac or general adverse effects. Influenza vaccine was found safe in CAD patients and antibody responses were similar to HCs.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk